Lenvatinib Plus Pembrolizumab in Previously Treated Advanced Endometrial Cancer: Updated Efficacy and Safety From the Randomized Phase III Study 309/KEYNOTE-775 The new score was developed using the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results